Target intelligence / Profile preview

Immunoglobulin heavy variable 1-1 (IGHV1-1)

Target
IGHV1-1
Molecular classification
Variable region gene segment of the immunoglobulin heavy chain locus, Immunoglobulin gene superfamily, Other
01

Overview

Immunoglobulin heavy variable 1-1 is a gene segment within the immunoglobulin heavy chain locus (IGH) containing the coding sequence for the variable region of the immunoglobulin heavy chain. These gene segments undergo somatic V(D)J recombination in developing B lymphocytes, generating the diverse antigen-binding sites of antibodies. It is not a classical receptor, enzyme, or drug target. Individual IGHV segments, such as IGHV1-1, contribute to antibody diversity and specificity but are not druggable themselves. Abnormal usage of certain IGHV genes may be associated with lymphoid malignancies or autoimmune diseases, although IGHV1-1 is not among the most commonly reported stereotyped IGHV segments. The submitted names "IGHVII-1-1" or "IGHV(II)-1-1" do not conform to major accepted nomenclature and likely arise from a misspelling or a non-standard nomenclature source.

Other names
IGHV1-1Immunoglobulin heavy chain variable region 1-1
02

Biological functions

Antigen bindingAdaptive immune responseV(D)J recombination during B cell development
03

Disease associations

Potential disease relevance if IGHV segment usage is skewed (e.g., some leukemias, lymphomas, or autoimmune disorders show stereotyped B cell receptor/IGHV usage)Other
04

Biomarkers

Skewed usage of certain IGHV segments can serve as biomarkers in specific B cell malignancies

Beyond the preview

Go deeper on Immunoglobulin heavy variable 1-1 (IGHV1-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 1-1 (IGHV1-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call